124 related articles for article (PubMed ID: 1330392)
1. Discordant hepatic uptake of Tc-99m NGA and Tc-99m PMT in a patient with hepatoma.
Aburano T; Shuke N; Yokoyama K; Tonami N; Hisada K; Tanei M; Terada M; Unoura M; Kobayashi K
Clin Nucl Med; 1992 Oct; 17(10):793-6. PubMed ID: 1330392
[TBL] [Abstract][Full Text] [Related]
2. Discordant uptake of Tc-99m PMT and Tc-99m GSA by two hepatocellular carcinoma lesions.
Tanabe Y; Hashimoto M; Ohuchi Y; Kodama F; Ogawa T
Ann Nucl Med; 2000 Dec; 14(6):485-8. PubMed ID: 11210102
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of Tc-99m PMT in adrenal metastasis of hepatoma.
Miyake H; Takeoka H; Wakisaka M; Mori H
Clin Nucl Med; 1991 Dec; 16(12):940-1. PubMed ID: 1663015
[No Abstract] [Full Text] [Related]
4. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.
Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S
Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of 99mTc-PMT in renal metastasis of hepatocellular carcinoma.
Shiozaki T; Hayakawa K; Tanikake M; Oida T; Hida S; Yasui H; Urata Y; Tanaka A; Morimoto T
Ann Nucl Med; 2003 Jun; 17(4):333-6. PubMed ID: 12932119
[TBL] [Abstract][Full Text] [Related]
6. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
[TBL] [Abstract][Full Text] [Related]
7. [Delayed Tc-99m-PMT imaging in the specific diagnosis of hepatocellular carcinoma].
Wu ZM
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):360-3. PubMed ID: 2854779
[TBL] [Abstract][Full Text] [Related]
8. Concentration and clearance of Tc-99m-pyridoxylidene isoleucine by a hepatoma.
Ueno K; Haseda Y
Clin Nucl Med; 1980 May; 5(5):196-9. PubMed ID: 6245828
[TBL] [Abstract][Full Text] [Related]
9. Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.
Hasegawa Y; Nakano S; Hiyama T; Sobue T; Yoshida H; Sasaki Y; Imaoka S; Inoue A; Tanaka S; Kusagai H
J Nucl Med; 1991 Feb; 32(2):228-35. PubMed ID: 1846910
[TBL] [Abstract][Full Text] [Related]
10. Utility of Tc-99m GSA whole-body scintigraphy in detecting bone metastases from hepatocellular carcinoma.
Sueyoshi K; Narabayashi I; Aratani T; Doi K; Komori T; Ogura Y; Utsunomiya K; Shimidzu T
Clin Nucl Med; 2001 Mar; 26(3):221-4. PubMed ID: 11245114
[TBL] [Abstract][Full Text] [Related]
11. Unusual early bile excretion from the liver in patients with fulminant hepatic failure as detected by Tc-99m-PMT hepatobiliary scintigraphy; comparison with Tc-99m-GSA scintigraphy.
Matsuoka S; Uchiyama K; Kuniyasu Y; Niio Y; Hasebe S; Shima H; Oishi S; Nojiri Y; Ogata H
Ann Nucl Med; 2001 Feb; 15(1):57-60. PubMed ID: 11355784
[TBL] [Abstract][Full Text] [Related]
12. Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma.
Hasegawa Y; Nakano S; Sobue T; Fujita M; Ishiguro S; Sasaki Y; Imaoka S; Tanaka S; Kasugai H; Inoue A
Ann Nucl Med; 1994 May; 8(2):139-45. PubMed ID: 7521195
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of 99mTc-PMT whole body scans in the diagnosis of bone metastases from hepatocellular carcinoma].
Nakanishi Y; Ha-Kawa SK
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Feb; 52(2):208-16. PubMed ID: 1313962
[TBL] [Abstract][Full Text] [Related]
14. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Sasaki Y; Imaoka S; Fujita M; Kawamoto S; Kasugai H
Cancer; 1986 Jan; 57(2):230-6. PubMed ID: 2417674
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
[TBL] [Abstract][Full Text] [Related]
16. A hepatobiliary study with Tc-99m N-pyridoxyl-5-methyltryptophan (PMT) in a patient with hepatoblastoma.
Ohshiro K; Hanashiro Y; Shimabukuro K; Hori A; Nagata Y; Matsumoto H; Uchima H
Clin Nucl Med; 1991 Jan; 16(1):10-2. PubMed ID: 1847848
[TBL] [Abstract][Full Text] [Related]
17. Metastasis of hepatocellular carcinoma to the colon demonstrated by Tc-99m PMT scintigraphy.
Fukui H; Kashiwagi T; Shirai Y; Matsuda Y; Kawata S; Nishimura T; Kozuka T
Clin Nucl Med; 1993 Jun; 18(6):512-5. PubMed ID: 8391407
[TBL] [Abstract][Full Text] [Related]
18. [6. Inspection of Hepatocellular Carcinoma 4: Nuclear Medicine Scan].
Odagiri H
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Jun; 72(6):522-9. PubMed ID: 27320156
[No Abstract] [Full Text] [Related]
19. [Two cases of skeletal metastasis of hepatocellular carcinoma demonstrating an abnormal accumulation of Tc-99m PMT].
Tada A; Tatsuno I; Takanaka T; Yasuda T; Wakabayashi T; Kinoshita M
Rinsho Hoshasen; 1987 Jan; 32(1):139-42. PubMed ID: 3033353
[No Abstract] [Full Text] [Related]
20. [Evaluation of 99mTc-PMT delayed imaging in diagnosis of hepatocellular carcinoma].
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Kasugai H; Tanaka S; Inoue A; Kojima J; Fujita M
Kaku Igaku; 1992 Mar; 29(3):367-76. PubMed ID: 1316500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
